Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MOTS-c vs NAD+: Research Applications Comparison

Metabolic Flexibility Models Upregulates AMPK, shifts fuel utilization toward fatty acid oxidation, improves insulin sensitivity in skeletal muscle and adipose tissue Provides cofactor for β-oxidation enzymes and TCA cycle function but does not directly alter

This comparison does not assign a generated winner or score.

  • Metabolic Flexibility Models
  • Upregulates AMPK, shifts fuel utilization toward fatty acid oxidation, improves insulin sensitivity in skeletal muscle and adipose tissue
  • Provides cofactor for β-oxidation enzymes and TCA cycle function but does not directly alter fuel preference signaling
  • MOTS-c is a regulatory signal; NAD+ is metabolic infrastructure
  • MOTS-c is the better choice when studying adaptive metabolic responses to caloric restriction or exercise
  • Mitochondrial Biogenesis
  • Activates PGC-1α transcription in nucleus, increases mitochondrial mass and oxidative capacity over 2–4 weeks
  • Required cofactor for sirtuins (especially SIRT1 and SIRT3) which regulate mitochondrial biogenesis via PGC-1α deacetylation
  • MOTS-c triggers biogenesis directly; NAD+ enables sirtuin-mediated biogenesis
  • Both compounds converge on PGC-1α but through different upstream pathways. Combined use may produce additive effects
  • DNA Repair Capacity
  • No direct role in DNA repair pathways
  • NAD+ is consumed by PARP1/2 enzymes during base excision repair and single-strand break repair
  • MOTS-c does not interact with DNA repair machinery; NAD+ is rate-limiting substrate
  • NAD+ is the only relevant compound for DNA damage response studies
  • Age-Related Insulin Resistance
  • Restores insulin sensitivity by increasing GLUT4 translocation and reducing ectopic lipid accumulation in muscle
  • Improves insulin signaling indirectly via SIRT1-mediated deacetylation of insulin receptor substrate proteins
  • MOTS-c acts on glucose transporter expression; NAD+ modulates post-translational insulin pathway regulation
  • MOTS-c shows faster insulin sensitivity improvement (2–3 weeks vs 4–6 weeks for NAD+ precursors in animal models)
  • Exercise Performance Enhancement
  • Increases endurance capacity by improving mitochondrial efficiency and reducing lactate accumulation during sustained aerobic effort
  • Enhances NAD+/NADH ratio during glycolysis, supporting ATP production but not altering metabolic substrate preference
  • MOTS-c changes how energy is produced; NAD+ changes how much energy can be produced
  • MOTS-c is more effective for metabolic endurance (fat oxidation during prolonged exercise); NAD+ supports high-intensity glycolytic output
More references

Related material